COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Mutations in the omicron variant of the SARS-CoV-2 virus may impact certain molecular tests for COVID-19, the Food and Drug Administration announced.
The Food and Drug Administration authorized administering bamlanivimab and etesivimab together to treat or prevent COVID-19 in all pediatric patients exposed to or testing positive for the virus who are at high risk for progressing to severe disease.
The Centers for Medicare & Medicaid Services will not enforce its COVID-19 vaccine mandate for health care workers while enjoined by district courts in Missouri and Louisiana, the agency confirmed in a memorandum.
The Centers for Medicare & Medicaid Services began requiring state Medicaid programs to cover counseling visits at which health care providers talk with families about COVID-19 vaccination for their children
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., expanded eligibility for COVID-19 booster shots to include all adults aged 18 and older who received a second dose of the Pfizer or Moderna vaccine at least six months ago, as recommended by the agency’s Advisory Committee…
Fall Preceptorship Session Three: The webinar identifies individual roles for managing the complexities of risk management in health care.
Texas filed a federal lawsuit challenging the Centers for Medicare & Medicaid Services’ interim final rule requiring COVID-19 vaccinations for workers in most health care settings that participate in the Medicare and Medicaid programs, including hospitals and health systems.
Nursing home visitation is now allowed for all residents at all times, according to updated guidance released by the Centers for Medicare & Medicaid Services.
To ensure that COVID-19 tests work as intended, the Food and Drug Administration will now enforce premarket review requirements for laboratory developed tests, reversing the prior administration’s policy, Health and Human Services Secretary Xavier Becerra announced.
The Centers for Disease Control and Prevention will implement three new ICD-10 diagnosis codes for reporting COVID-19 vaccination status effective April 1, 2022.